Clinical assessment of azapropazone in rheumatoid arthritis

David M. Grennan The Centre for Rheumatic Diseases, and University Department of Medicine, Royal Infirmary, Glasgow, Scotland

Marion McLeod The Centre for Rheumatic Diseases, and University Department of Medicine, Royal Infirmary, Glasgow, Scotland

Caroline Watkins The Centre for Rheumatic Diseases, and University Department of Medicine, Royal Infirmary, Glasgow, Scotland

W. Carson Dick The Centre for Rheumatic Diseases, and University Department of Medicine, Royal Infirmary, Glasgow, Scotland

Summary

Azapropazone was investigated in a 2-week double-blind clinical out-patient trial against placebo in 23 patients with definite rheumatoid arthritis. The drug was given at a dose of 1200 mg. per day before food. At this dose level the drug was shown to have an antirheumatic effect in terms of pain relief, articular tenderness and duration of morning stiffness.

Key Words::

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Clinical assessment of azapropazone in rheumatoid arthritis

Information for

Open access

Opportunities

Help and information

Clinical assessment of azapropazone in rheumatoid arthritis

Summary

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature